<DOC>
	<DOCNO>NCT00150098</DOCNO>
	<brief_summary>To determine efficacy enhance HIV risk reduction intervention deliver concurrently vaccination schedule reduce number unprotected vaginal anal sex act among HIV-negative , high-risk non-injection drug-using ( NIDU ) woman . To determine efficacy enhanced vaccine education intervention deliver baseline increase vaccine knowledge understand potential HIV vaccine among HIV-negative , high-risk NIDU woman .</brief_summary>
	<brief_title>Project UNITY - HIV Risk Reduction Vaccine Education Interventions</brief_title>
	<detailed_description>We currently screen woman ( approximately 535 ) expect 400 HIV-negative high-risk , non-pregnant NIDU woman enrol participate two-arm randomize trial enhance HIV risk reduction intervention plus enhanced vaccine education intervention compare control . At screen , woman complete assessment , receive HIV HBV pre-test counseling , test HIV antibody , marker hepatitis B virus ( HBV ) infection pregnancy . At enrollment visit ( 2 week later ) , eligible willing participant randomize receive either enhance HIV risk reduction intervention plus enhanced vaccine education intervention control condition . Enrolled woman provide urine pregnancy test . Enrolled woman find susceptible HBV offer hepatitis B ( HB ) vaccine enrollment visit . Follow-up visit coincide HB vaccine schedule ( 1 6 month post enrollment ) woman , regardless whether receive HB vaccine . Pregnancy test conduct follow-up visit . Participants provide serum HIV antibody test 6- 12-months visit . A final visit occur 12 month post enrollment ass long term effect risk behavior knowledge understanding vaccine concept . All standardized interview conduct use Audio Computer Assisted Self-Interview ( ACASI ) technology . The enhanced HIV risk reduction intervention series three , interactive , individually-delivered , counseling session . The enhanced session also include tailored male female condom demonstration build skill , session conclude client-initiated sexual risk reduction goal . The follow-up session ( 1 6 month ) resume review goal attainment , explore reason beliefs associate progress toward goal . The control group receive client-centered HIV counseling base Centers Disease Control Prevention ( CDC ) Project RESPECT model . Both control enhance risk reduction counsel deliver baseline ( time 0 ) follow visit ( 1 month 6 month ) . The enhanced vaccine education component test two-session model informed consent process outline Coletti et al enhance simplify illustrated educational material deliver flipcharts , video individual counseling baseline 1 week later . The control condition base Coletti two-session informed consent process .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>least 18 year age ; noninjecting use heroin , cocaine crack cocaine last six month ; unprotected vaginal sex last three month ; test HIV antibody negative ; agree provide specimen test ( HIV , HBV pregnancy ) willing learn result test ; ability understand speak English Spanish ; agree randomize ; willing return visit 1 , 6 , 12 month postenrollment ; willing able provide inform consent . history injection drug use previous 3 year ; pregnant ; intend become pregnant next 12 month .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>HIV</keyword>
	<keyword>vaccine</keyword>
	<keyword>woman</keyword>
	<keyword>substance use</keyword>
</DOC>